FFRct vs Study Watch with Irregular Pulse Monitor (Home)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (FFRct) is a diagnostic tool that uses AI to analyze CCTA scans for coronary artery disease, providing insights into blood flow and aiding in treatment decisions. Tool B (Study Watch) is a wearable device focused on remote physiological monitoring, specifically designed for detecting irregular pulses and atrial fibrillation. While both fall under Cardiology AI, they address different clinical needs: advanced imaging diagnostics versus continuous cardiac rhythm monitoring.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is designed for the non-invasive diagnosis of coronary artery disease (CAD) by creating personalized 3D models of coronary arteries from CCTA scans to assess blood flow and aid in treatment strategies. The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device primarily for clinical research and healthcare use, focusing on unobtrusive collection of physiological data, including on-demand single-channel ECG measurement and irregular pulse monitoring for atrial fibrillation (AFib) detection.
FFRct Analysis utilizes existing CCTA (Coronary Computed Tomography Angiography) scans, processing the DICOM data to generate 3D models and assess blood flow. In contrast, the Verily Study Watch is a wearable device that directly collects physiological data from the patient through its advanced sensors, such as ECG, heart rate, and electrodermal activity.
HeartFlow FFRct Analysis has a defined CMS payment rate of $1,017 for 2025, and it transitioned to a Category I CPT code (75580) as of January 1, 2024, reinforcing its reimbursement. The Verily Study Watch's pricing is not publicly available as it is intended for clinical research and prescription use, not direct consumer sale.
HeartFlow FFRct Analysis is best suited for patients with symptomatic acute or stable chest pain and observed coronary plaque on a CCTA, particularly those with intermediate lesions, to aid in diagnosing coronary artery disease (CAD) and guiding revascularization decisions. The Verily Study Watch is designed for clinical research and prescription use, focusing on collecting physiological data for conditions like atrial fibrillation (AFib) detection and has been used in studies for Parkinson's disease and heart failure.
HeartFlow FFRct Analysis provides personalized 3D digital models of coronary arteries, analyzing blood flow and identifying areas of narrowing with FFRct values to integrate anatomical and physiological data from CCTA. The Verily Study Watch offers on-demand single-channel ECG measurements, irregular pulse monitoring for AFib detection, and data from multiple physiological sensors including heart rate, electrodermal activity, and inertial movements.